As of Feb 17
| +0.60 / +1.14%|
The 11 analysts offering 12-month price forecasts for Medicines Co have a median target of 52.00, with a high estimate of 65.00 and a low estimate of 39.00. The median estimate represents a -2.62% decrease from the last price of 53.40.
The current consensus among 11 polled investment analysts is to Buy stock in Medicines Co. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.